A close relationship between gastric NENs and adenocarcinomas of the stomach has been described [35], and the preservation of the CCKBR on gastric cancer cells may similarly to gastric NETs make them susceptible for treatment with a CCKBR antagonist (netazepide). This evidence concerns the gene CCKBR and gastric adenocarcinoma.